What is Pfizer's accumulated depreciation?

Pfizer (PFE) reported accumulated depreciation of $17.80B in Q1 2026.

How has Pfizer's accumulated depreciation changed year-over-year?

Pfizer's accumulated depreciation increased by 5.7% year-over-year, from $16.84B to $17.80B.

What is the long-term trend for Pfizer's accumulated depreciation?

Over 5 years (2020 to 2025), Pfizer's accumulated depreciation has grown at a 3.3% compound annual growth rate (CAGR), from $14.81B to $17.39B.

Non-Current Assets

Accumulated Depreciation

Pfizer Accumulated Depreciation increased by 2.4% to $17.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.7%, from $16.84B to $17.80B. Over 5 years (FY 2020 to FY 2025), Accumulated Depreciation shows an upward trend with a 3.3% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

First reportedQ4 2015

Last reportedQ1 2026May 5, 2026

Parent metricPP&E (Net)

Metric ID: ppe_accumulated_depreciation

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$15.33B	$15.40B	$15.07B	$15.36B	$14.97B	$14.93B	$15.17B	$15.51B	$15.55B	$15.78B	$16.05B	$16.36B	$16.57B	$16.68B	$16.48B	$16.84B	$17.27B	$17.51B	$17.39B	$17.80B
QoQ Change	—	+0.5%	-2.1%	+1.9%	-2.5%	-0.3%	+1.6%	+2.2%	+0.3%	+1.4%	+1.7%	+2.0%	+1.3%	+0.6%	-1.2%	+2.2%	+2.5%	+1.4%	-0.7%	+2.4%
YoY Change	—	—	—	—	-2.3%	-3.1%	+0.7%	+1.0%	+3.9%	+5.7%	+5.7%	+5.5%	+6.5%	+5.7%	+2.7%	+2.9%	+4.2%	+5.0%	+5.5%	+5.7%
% of PP&E (Net)	107.8%	106.7%	101.3%	101.6%	98.2%	96.7%	93.2%	91.0%	88.9%	88.3%	84.7%	87.0%	87.4%	89.9%	89.6%	91.8%	92.0%	92.7%	90.0%	91.8%
Share Change	—	-1.1pp	-5.4pp	+0.4pp	-3.5pp	-1.5pp	-3.5pp	-2.3pp	-2.0pp	-0.6pp	-3.6pp	+2.3pp	+0.4pp	+2.5pp	-0.3pp	+2.2pp	+0.2pp	+0.7pp	-2.7pp	+1.8pp

Range$14.93B – $17.80B

CAGR+3.2%

Avg YoY Growth+3.5%

Median YoY Growth+4.6%

Accumulated Depreciation at Other Companies

Johnson & JohnsonJNJ View metric

Merck & Co.MRK View metric

AmgenAMGN View metric

IncyteINCY View metric

AbbVieABBV View metric

ModernaMRNA View metric

Frequently Asked Questions

What is Pfizer's accumulated depreciation?: Pfizer (PFE) reported accumulated depreciation of $17.80B in Q1 2026.
How has Pfizer's accumulated depreciation changed year-over-year?: Pfizer's accumulated depreciation increased by 5.7% year-over-year, from $16.84B to $17.80B.
What is the long-term trend for Pfizer's accumulated depreciation?: Over 5 years (2020 to 2025), Pfizer's accumulated depreciation has grown at a 3.3% compound annual growth rate (CAGR), from $14.81B to $17.39B.